Plus, news about Ashvattha, Bausch + Lomb, Whitecap Biosciences, Labviva, Scribe, Sanofi, X4, Apellis and Aileron Therapeutics:
Immunovant nets $450M private placement: The proceeds will help afford a large clinical development program for lead asset IMVT ...
↧